Zus Health has raised $33 million in Series B funding to build the data layer it says healthcare AI needs before copilots and agents can be trusted at the bedside. Drive Capital led the round, which takes the Boston company’s total funding past $100 million, Fierce Healthcare reported on November 12.
Sanofi Ventures, HealthX Ventures and Alumni Ventures joined the round, alongside existing investors Andreessen Horowitz, F-Prime, Maverick Ventures and JAZZ Venture Partners. The company announced the financing on November 10.
What Was Announced
Zus Health, founded in 2021 by former athenahealth chief executive Jonathan Bush, is betting that AI in healthcare will fail without reliable patient data underneath it. Electronic health records digitized medicine but left information scattered across organizations, so clinicians still spend valuable time hunting for records and reconciling incomplete files. Zus wants to fix that layer first, then build AI workflows on top of it.
The platform has three layers, according to Bush. The first is a nationwide patient record. The second is a data network that pulls information into that record from electronic health record systems, pharmacies, labs and care event notifications. The third is AI-enabled workflows that automate care tasks using a more complete view of the patient. Bush describes the record as an “always-on, FHIR-native, API-first medical record,” available through a standalone app, an API, embedded components and direct integration with electronic health record systems.

A doctor reviews patient data during a telemedicine consultation. Image: Wikimedia Commons (CC BY-SA)
At the center sits the Zus Aggregated Profile, known as ZAP, which pulls fragmented clinical information into a single longitudinal patient record, with AI-powered clinical intelligence layered on top. The company’s Generated Patient Summaries tool turns unstructured medical histories into concise summaries for care teams. Zus says its network covers more than 270 million patients across 70,000 provider sites.
The scale figures the company disclosed point to real usage. In August alone, its nationwide network supported more than 110 million networked transactions, while its AI-native clinical platform generated 39 million evidence citations year-to-date across its products.
Why It Matters
Healthcare AI has a data problem that model quality alone cannot solve. A copilot that reads only one clinic’s records will miss the cardiologist’s note, the pharmacy refill and the lab result from another system, and in medicine a missing fact can be a wrong decision. Zus is arguing that the winning position is not the best model but the most complete and current patient record, and that whoever owns that record becomes the platform every clinical AI application runs on.
“We’re finally on to the last and critical piece of what I think the future of medical records looks like, which is standing up workflows that automate all of the tasks of patient care in a very bespoke way,” Bush told Fierce Healthcare. He added that Zus had “developed the first data-rich networked medical record platform in the industry’s history.”

Graphic: GPTOnline, using Zus Health assets
The funding will go toward expanding AI-powered clinical intelligence, broadening data network connectivity and automating population health and care management workflows. The company is seeing rapid growth in specialty care, particularly oncology, where complex patient records are spread across multiple providers and treatment eligibility, clinical trial criteria and genetic testing reviews traditionally require heavy manual work by nurses and analysts.
Zus is also pursuing a bigger institutional role. In August 2026 it announced its candidacy to become a Qualified Health Information Network under the Trusted Exchange Framework and Common Agreement, the national framework for health information exchange. That process takes roughly a year, but a QHIN designation would put Zus at the center of how US health data moves between organizations.
“We believe healthcare is entering a new era in which AI can fundamentally change how care is delivered, but that transformation depends on having reliable, connected patient information,” said Molly Bonakdarpour, general partner at Drive Capital, in a statement. “Zus has built the foundation to address that challenge at scale.”
Sources
- Fierce Healthcare, “Zus Health raises $33M to build the data layer for healthcare AI,” November 12, 2026
- GlobeNewswire (via Manila Times), “Zus Health Raises $33 Million in Series B Funding to Accelerate the Next Generation of Connected Healthcare,” November 10, 2026
- Zus Health (zushealth.com), company website

